about
Highlights in pathogenesis of vitiligoVitiligo--part 1Blood antioxidant status and urinary levels of catecholamine metabolites in beta-thalassemiaVitiligo puzzle: the pieces fall in place.Increased Risk of Metabolic Syndrome in Patients with Vitiligo.Erythrocyte malondialdehyde and glutathione levels in vitiligo patients.Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibilityPotential redox-sensitive Akt activation by dopamine activates Bad and promotes cell death in melanocytesUnderstanding mechanisms of vitiligo development in Smyth line of chickens by transcriptomic microarray analysis of evolving autoimmune lesions.Vitiligo road map.Vitiligo and depression: a systematic review and meta-analysis of observational studies.Vitiligo, reactive oxygen species and T-cells.Potential role of neurogenic inflammatory factors in the pathogenesis of vitiligo.The pathogenesis of vitiligo.Stability in Vitiligo: Is there a Perfect Way to Predict it?Whole Transcriptome Analysis (RNA Sequencing) of Peripheral Blood Mononuclear Cells of Vitiligo Patients.Is Lesional Stability in Vitiligo More Important Than Disease Stability for Performing Surgical Interventions? Results from a Multicentric Study.The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.Increase in total blood antioxidant status and selenium levels in black patients with active vitiligo.Corticotropin-releasing hormone (CRH) and CRH receptor 1 gene expression in vitiligo.Neural and Endocrinal Pathobiochemistry of Vitiligo: Comparative Study for a Hypothesized Mechanism.
P2860
Q26851509-26170185-7930-47F2-9D50-13C5EC6E92C5Q27028001-932B3ABF-D296-482C-8D0B-E14791577B98Q28368958-4D8A2BEB-8909-4179-81A9-C9ED5BF64E83Q33344607-B3356F79-5A96-4766-B670-EDD98C33E054Q33745258-E04B5EA8-A390-42F1-89F3-BAD16D613F75Q34050814-E4F217C3-8979-47A2-8D28-1F5CCEBBF311Q34183603-10EB0FC7-B472-4A2D-9E54-F3763DDE71A9Q34185787-58DA0C9B-501B-4368-9973-1254A632E6EAQ34231900-EB1CD384-8099-4957-9435-E2613DFC7088Q34511375-E5158C6E-3CAA-4A38-A5FC-F0ECA5957C78Q36202179-ACC6D314-0989-4A40-80A6-E29336EDE92DQ37801388-50F71766-96D3-4F01-B864-D1AA679B3189Q38025487-369F31A5-8188-4E9E-A7D9-A663EADB8903Q38106804-4E8FC6A8-F0DA-4F04-8B62-090387DD8FD9Q38136173-6348BAD5-EC5E-450B-B30D-42163229D571Q38700035-4A95861F-66D9-4D9A-B80E-28B0C0A05040Q39662641-2A4C31E8-53AB-4403-A9CF-8E9AAAC88B35Q42518695-B6B32C28-4161-48A7-BF99-6F9499A08DB3Q44186912-B322ECBB-9432-4768-826F-949D0E7F73BEQ48497157-41E39CD3-AB07-47A2-A557-6FA59DF98AC8Q55380689-DF1C2C0B-25F3-4A09-9D56-E789FBDBD44A
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մարտին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Catecholamines and vitiligo.
@ast
Catecholamines and vitiligo.
@en
Catecholamines and vitiligo.
@nl
type
label
Catecholamines and vitiligo.
@ast
Catecholamines and vitiligo.
@en
Catecholamines and vitiligo.
@nl
prefLabel
Catecholamines and vitiligo.
@ast
Catecholamines and vitiligo.
@en
Catecholamines and vitiligo.
@nl
P2093
P1476
Catecholamines and vitiligo.
@en
P2093
P2860
P356
10.1111/J.1600-0749.1992.TB00003.X
P577
1992-03-01T00:00:00Z